AtG is a spin-off company from the Bellvitge Biomedical Research Institute (IDIBELL) and the Catalan Institute of Oncology (ICO) in Barcelona that specialized in the discovery and development of new therapeutic techniques for cancer resistance to improve the lives of cancer patients.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.